19.10
2.91%
0.54
Precedente Chiudi:
$18.56
Aprire:
$18.9065
Volume 24 ore:
2,063
Relative Volume:
0.45
Capitalizzazione di mercato:
$444.37M
Reddito:
$1.70M
Utile/perdita netta:
$-47.01M
Rapporto P/E:
-11.24
EPS:
-1.7
Flusso di cassa netto:
$-157.28M
1 W Prestazione:
+3.24%
1M Prestazione:
+3.47%
6M Prestazione:
-14.23%
1 anno Prestazione:
-24.06%
Puretech Health Plc Adr Stock (PRTC) Company Profile
Nome
Puretech Health Plc Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta PRTC con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
PRTC
Puretech Health Plc Adr
|
19.10 | 444.37M | 1.70M | -47.01M | -157.28M | -1.70 |
VRTX
Vertex Pharmaceuticals Inc
|
469.20 | 112.90B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
684.01 | 75.06B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
660.38 | 40.45B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.89 | 35.75B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
123.90 | 28.98B | 3.30B | -501.07M | 1.03B | -2.1146 |
Puretech Health Plc Adr Stock (PRTC) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-09-09 | Ripresa | Leerink Partners | Outperform |
Puretech Health Plc Adr Borsa (PRTC) Ultime notizie
Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.
PureTech Health stock hits 52-week low at $16.81 amid market shifts By Investing.com - Investing.com South Africa
PureTech Health stock hits 52-week low at $16.81 amid market shifts - Investing.com India
PureTech to present at J.P. Morgan Healthcare Conference - Investing.com
PureTech reports positive LYT-200 trial results in AML/MDS - Investing.com
Rubrik Reports Q2 Results, Joins Ionis Pharmaceuticals, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
South Korea Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
PureTech Health (LON:PRTC) Share Price Crosses Below 50-Day Moving Average of $175.96 - Defense World
Asia Pacific Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
PureTech Health: Results of the Tender Offer - StockTitan
PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team - Business Wire
PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share - Yahoo Finance
PureTech Health (PRTC) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
The definitive Boston biotech layoff tracker for 2023 - The Business Journals
Wall Street Analysts Predict an 82% Upside in PureTech Health PLC Sponsored ADR (PRTC): Here's What You Should Know - Yahoo Finance
PureTech Announces Annual Results for Year Ended December 31, 2020 - Samoa Observer
Puretech Health Plc Adr Azioni (PRTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):